Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Malignant struma ovarii.

N G Rosenblum1, V A LiVolsi, P R Edmonds

  • 1Department of Obstetrics and Gynecology, Hospital of the University of Pennsylvania, Philadelphia 19104.

Gynecologic Oncology
|February 1, 1989
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A comparison of the histopathologic features of thyroid carcinomas with NTRK fusions to those with other malignant fusions.

Human pathology·2024
Same author

Differentiated high grade thyroid carcinomas: Diagnostic consideration and clinical features.

Human pathology·2024
Same author

An investigation into noninvasive follicular thyroid neoplasms with papillary-like nuclear features: does the initial proposal on noninvasive follicular thyroid neoplasms with papillary-like nuclear features behavior hold true?

Human pathology·2023
Same author

The Enlarged Fibroid Uterus: Aberrant Arterial Supply via the Omental Artery.

Cardiovascular and interventional radiology·2018
Same author

Pre-operative features of non-invasive follicular thyroid neoplasms with papillary-like nuclear features: An analysis of their cytological, Gene Expression Classifier and sonographic findings.

Cytopathology : official journal of the British Society for Clinical Cytology·2017
Same author

The effects of frozen tissue storage conditions on the integrity of RNA and protein.

Biotechnic & histochemistry : official publication of the Biological Stain Commission·2014
Same journal

Toward precision prognosis: Predicting recurrence-free survival in high-grade serous ovarian cancer patients using multi-time point clinical and computed tomography radiomics data.

Gynecologic oncology·2026
Same journal

Adjunctive sodium-glucose cotransporter 2 (SGLT2) inhibitors with progestins and endometrial cancer risk in benign uterine diseases and hyperplasia.

Gynecologic oncology·2026
Same journal

Updated patient-reported outcomes and the effect of disease progression on health-related quality of life in the PRIMA/ENGOT-OV26/GOG-3012 trial of niraparib first-line maintenance therapy in patients with newly diagnosed advanced ovarian cancer.

Gynecologic oncology·2026
Same journal

PRO-PLATINUM: A randomized, double-blind, placebo controlled study to investigate the efficacy of a probiotic intervention on the gut and vaginal microbiome of ovarian cancer patients undergoing treatment with platinum chemotherapy.

Gynecologic oncology·2026
Same journal

A second chance for the second look: Feasibility of laparoscopic HIPEC at the conclusion of upfront treatment for epithelial ovarian cancer.

Gynecologic oncology·2026
Same journal

Prognostic impact of time to first recurrence in low-grade serous ovarian carcinoma: A multicentric retrospective study from the French TMRG network.

Gynecologic oncology·2026
See all related articles

Malignant struma ovarii is a rare tumor. This case explores intraperitoneal chronic phosphate for metastatic disease, suggesting prophylactic thyroid hormone is crucial.

Area of Science:

  • Gynecologic Oncology
  • Endocrinology
  • Nuclear Medicine

Background:

  • Malignant struma ovarii, a rare ovarian tumor of thyroid tissue, presents diagnostic challenges.
  • Prognosis is often uncertain due to limited follow-up and long clinical courses.
  • Standard treatment involves surgery, but metastatic disease requires further management.

Observation:

  • A case of malignant struma ovarii with intraperitoneal metastasis is presented.
  • The study details the use of intraperitoneal chronic phosphate (32P) for treating widespread intraperitoneal disease.
  • Thyroid suppression therapy was administered concurrently.

Findings:

  • Surgical treatment is often effective, but mortality can occur with metastasis.
  • Radioactive iodine has shown efficacy in treating metastatic struma ovarii.

Related Experiment Videos

  • Intraperitoneal chronic phosphate (32P) was utilized for intraperitoneal metastatic disease, alongside thyroid suppression.

    • Implications:

    • Long-term follow-up is essential to evaluate the efficacy of intraperitoneal 32P therapy.
    • Prophylactic thyroid hormone administration should be strongly considered in managing malignant struma ovarii.
    • This case contributes to understanding treatment options for rare, metastatic ovarian teratomas.